Company Profile

Attogen Inc
Profile last edited on: 5/20/20      CAGE: 47JQ4      UEI:

Business Identifier: Monoclonal antibodies and peptides
Year Founded
2003
First Award
2008
Latest Award
2010
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

100 Barber Avenue
Worcester, MA 01606
   (781) 259-8108
   support@attogenbio.com
   www.attogenbio.com
Location: Single
Congr. District: 02
County: Worcester

Public Profile

Attogen Biomedical Research specializes in antibody products that are not typically found in large antibody catalogs. Through the company's partnerships with leading edge cancer researchers, many of the firm's specialty Mabs are one-of-a-kind, either to targets that are not available elsewhere, or exhibiting unique characteristics in the form of specificity or affinity or optimized application

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 1 NIH $248,848
Project Title: PA22176, SBIR, Phase I, Lateral Flow Assay to Detect Malaria
2010 1 NIH $188,238
Project Title: A Novel Anti-Endotoxin Peptide for Septic Shock
2008 1 NIH $185,061
Project Title: Antibody Therapeutics - Feasibility Study on Hormone-Refrectory Prostate Cancer M

Key People / Management

  Harry G McCoy -- Chairman

  Jia X Chang -- CSO

  Xiao-Jia Chang

  Joseph Francis Krebs

  Ullrich Schwertschlag -- CMO

  Katherine Turner -- CDO

Company News

There are no news available.